Position in GILD
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$108,970,397
-$745,987 QoQ
Shares Held
862,517
+9.6% QoQ
Ownership
0.070%
of shares outstanding
% of Portfolio
0.30%
of 13F equity value
Holder Rank
#136
of 2,265 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 87%
Shared 0%
None 13%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Eurizon Capital SGR S.p.A. holds $1,998,617,994 across 10 Drug Manufacturers - General names. GILD ranks #5 (5.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
429,150 | $514,735,427 | |
| 2 | JNJ |
Johnson & Johnson
|
1,860,763 | $472,577,979 | |
| 3 | ABBV |
AbbVie Inc.
|
1,515,159 | $381,274,610 | |
| 4 | MRK |
Merck & Co., Inc.
|
2,398,834 | $308,250,169 | |
| 5 | GILD |
Gilead Sciences, Inc.
This page
|
862,517 | $108,970,397 | |
| 6 | AMGN |
Amgen Inc
|
270,033 | $97,784,349 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
1,230,296 | $70,889,655 | |
| 8 | BIIB |
Biogen Inc.
|
102,594 | $22,166,459 |
All Filings in GILD
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $108,970,397 | 862,517 | Shares | Other | 2026-07-29 | |
| 2026-03-31 | $109,716,384 | 787,231 | Shares | Other | 2026-05-08 | |
| 2025-12-31 | $117,397,127 | 956,470 | Shares | Other | 2026-02-10 | |
| No filing history on record for this holder in this stock. | ||||||